217 related articles for article (PubMed ID: 34346836)
1. Identification of four gastric cancer subtypes based on genetic analysis of cholesterogenic and glycolytic pathways.
Zhu Z; Qin J; Dong C; Yang J; Yang M; Tian J; Zhong X
Bioengineered; 2021 Dec; 12(1):4780-4793. PubMed ID: 34346836
[TBL] [Abstract][Full Text] [Related]
2. Identification of Four Metabolic Subtypes of Glioma Based on Glycolysis-Cholesterol Synthesis Genes.
Zhang J; Xiao X; Guo Q; Wei Z; Hua W
Comput Math Methods Med; 2022; 2022():9448144. PubMed ID: 35242216
[TBL] [Abstract][Full Text] [Related]
3. Identification of subgroups along the glycolysis-cholesterol synthesis axis and the development of an associated prognostic risk model.
Zhang E; Chen Y; Bao S; Hou X; Hu J; Mu OYN; Song Y; Shan L
Hum Genomics; 2021 Aug; 15(1):53. PubMed ID: 34384498
[TBL] [Abstract][Full Text] [Related]
4. Altered gene expression in glycolysis-cholesterol synthesis axis correlates with outcome of triple-negative breast cancer.
Zhong PC; Shu R; Wu HW; Liu ZW; Shen XL; Hu YJ
Exp Biol Med (Maywood); 2021 Mar; 246(5):560-571. PubMed ID: 33243007
[TBL] [Abstract][Full Text] [Related]
5. Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration.
Zhang Y; Zhu B; Cai Y; Zhu S; Zhao H; Ying X; Jiang C; Zeng J
BMC Cancer; 2022 Jan; 22(1):2. PubMed ID: 34980012
[TBL] [Abstract][Full Text] [Related]
6. Alterations in glycolytic/cholesterogenic gene expression in hepatocellular carcinoma.
Jiang J; Zheng Q; Zhu W; Chen X; Lu H; Chen D; Zhang H; Shao M; Zhou L; Zheng S
Aging (Albany NY); 2020 Jun; 12(11):10300-10316. PubMed ID: 32479426
[TBL] [Abstract][Full Text] [Related]
7. Aberrant gene expression pattern in the glycolysis-cholesterol synthesis axis is linked with immune infiltration and prognosis in prostate cancer: A bioinformatics analysis.
Yuan Y; Song J; Wu Q
Medicine (Baltimore); 2022 Oct; 101(43):e31416. PubMed ID: 36316896
[TBL] [Abstract][Full Text] [Related]
8. Altered Gene Expression along the Glycolysis-Cholesterol Synthesis Axis Is Associated with Outcome in Pancreatic Cancer.
Karasinska JM; Topham JT; Kalloger SE; Jang GH; Denroche RE; Culibrk L; Williamson LM; Wong HL; Lee MKC; O'Kane GM; Moore RA; Mungall AJ; Moore MJ; Warren C; Metcalfe A; Notta F; Knox JJ; Gallinger S; Laskin J; Marra MA; Jones SJM; Renouf DJ; Schaeffer DF
Clin Cancer Res; 2020 Jan; 26(1):135-146. PubMed ID: 31481506
[TBL] [Abstract][Full Text] [Related]
9. Interaction between glycolysis‒cholesterol synthesis axis and tumor microenvironment reveal that gamma-glutamyl hydrolase suppresses glycolysis in colon cancer.
Chen YJ; Guo X; Liu ML; Yu YY; Cui YH; Shen XZ; Liu TS; Liang L
Front Immunol; 2022; 13():979521. PubMed ID: 36569910
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Scoring System Based on 9 Glycolysis-Related Genes for Prognosis Prediction in Gastric Cancer.
Luo T; Du Y; Duan J; Liang C; Chen G; Jiang K; Chen Y; Chen Y
Technol Cancer Res Treat; 2020; 19():1533033820971670. PubMed ID: 33161837
[TBL] [Abstract][Full Text] [Related]
11. Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.
Lei Z; Tan IB; Das K; Deng N; Zouridis H; Pattison S; Chua C; Feng Z; Guan YK; Ooi CH; Ivanova T; Zhang S; Lee M; Wu J; Ngo A; Manesh S; Tan E; Teh BT; So JB; Goh LK; Boussioutas A; Lim TK; Flotow H; Tan P; Rozen SG
Gastroenterology; 2013 Sep; 145(3):554-65. PubMed ID: 23684942
[TBL] [Abstract][Full Text] [Related]
12. Prognosis-related molecular subtyping in head and neck squamous cell carcinoma patients based on glycolytic/cholesterogenic gene data.
Zhou Z; Tang J; Lu Y; Jia J; Luo T; Su K; Dai X; Zhang H; Liu O
Cancer Cell Int; 2023 Feb; 23(1):37. PubMed ID: 36841765
[TBL] [Abstract][Full Text] [Related]
13. Identification and Development of Subtypes With Poor Prognosis in Pan-Gynecological Cancer Based on Gene Expression in the Glycolysis-Cholesterol Synthesis Axis.
Wang G; Liu X; Wang D; Sun M; Yang Q
Front Oncol; 2021; 11():636565. PubMed ID: 33842342
[No Abstract] [Full Text] [Related]
14. Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.
Mo W; Ding Y; Zhao S; Zou D; Ding X
PLoS One; 2020; 15(11):e0241924. PubMed ID: 33170908
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of differing metabolic dysregulations, a glucose driven and another fatty acid centric in gastric cancer subtypes.
Balakrishnan K; Ganesan K
Funct Integr Genomics; 2020 Nov; 20(6):813-824. PubMed ID: 32949316
[TBL] [Abstract][Full Text] [Related]
16. Global expression profiling of metabolic pathway-related lncRNAs in human gastric cancer and the identification of RP11-555H23.1 as a new diagnostic biomarker.
Mo X; Wu Y; Chen L; Zhai M; Gao Z; Hu K; Guo J
J Clin Lab Anal; 2019 Feb; 33(2):e22692. PubMed ID: 30320481
[TBL] [Abstract][Full Text] [Related]
17. HMGA1 promoting gastric cancer oncogenic and glycolytic phenotypes by regulating c-myc expression.
Cao XP; Cao Y; Zhao H; Yin J; Hou P
Biochem Biophys Res Commun; 2019 Aug; 516(2):457-465. PubMed ID: 31229266
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer analysis of clinical significance and associated molecular features of glycolysis.
Liu YC; Lin P; Zhao YJ; Wu LY; Wu YQ; Peng JB; He Y; Yang H
Bioengineered; 2021 Dec; 12(1):4233-4246. PubMed ID: 34304708
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of a Glycolytic Signature and Its Regulation by Y-Box-Binding Protein 1 in Triple-Negative Breast Cancer.
Lai YW; Hsu WJ; Lee WY; Chen CH; Tsai YH; Dai JZ; Yang CC; Lin CW
Cells; 2021 Jul; 10(8):. PubMed ID: 34440660
[TBL] [Abstract][Full Text] [Related]
20. Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer.
Kim SK; Kim HJ; Park JL; Heo H; Kim SY; Lee SI; Song KS; Kim WH; Kim YS
Gastric Cancer; 2020 May; 23(3):473-482. PubMed ID: 31773340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]